Physician Wealth Advisors’s Cognyte Software CGNT Stock Holding History

Physician Wealth Advisors’s Portfolio CGNT Stock Details CGNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$492	Buy	+56	New	+$531	﹤0.01%	2138

Other funds holding CGNT

Edenbrook Capital Mt. Kisco, New York $496M AUM 53.85% 1-Year Est. Return

Value Base Tel Aviv, Israel $162M AUM 2.31% 1-Year Est. Return

ACM

American Capital Management New York $2.23B AUM 28.03% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

TCM

Topline Capital Management Santa Monica, California $386M AUM 2.37% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

YDMI

Y.D. More Investments Ramat Gan, Israel $3.21B AUM 117.29% 1-Year Est. Return

Samjo Management New York $293M AUM 57.03% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Physician Wealth Advisors's CGNT Position: Q2 2026 in Review

Physician Wealth Advisors opened a new position in Cognyte Software (CGNT) in Q2 2026: 56 shares worth $492. The stake represents ﹤0.01% of the portfolio and ranks #2138 among its holdings.

135 funds tracked by Wall St. Rank hold CGNT as of Q2 2026.

Physician Wealth Advisors held 56 shares of Cognyte Software worth $492 as of Q2 2026.
Cognyte Software was a new Physician Wealth Advisors position in Q2 2026.
Cognyte Software made up ﹤0.01% of Physician Wealth Advisors's portfolio in Q2 2026, its #2138 holding.
135 funds tracked by Wall St. Rank held Cognyte Software as of Q2 2026.

Based on Physician Wealth Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.